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PENGAYAAN PROTEIN OLEH PYCNOPORUS SANGUINEUS UNTUK 
SINTESIS ZARAH NANO-AGENTUM  
ABSTRAK 
Pengawalan saiz nanobahan telah menarik perhatian kerana sifatnya yang unik untuk 
mencapai sesuatu proses, terutamanya dalam aplikasi biologi dan perubatan. Dalam 
konteks ini, unsure agendum (Ag) yang mempunyai kesan antimikrob yang baik, 
adalah penting. Pendekatan yang mudah dan berkesan untuk sintesis zarah nano-
agentum dengan mekanisme pengurangan protein yang dihasilkan oleh beberapa 
spesies kulat reput putih telah dikaji. Pycnoporus sanguineus telah didapati boleh 
menghasilkan saiz zarah nano Ag yang terkecil dengan tahap“monodispersity”. 
Rekabentuk Box-Behnken telah diguna untuk mengoptimumkan media fermentasi 
untuk penghasilan protein dengan kulat yang dipilih. Empat pembolehubah yang 
terlibat dalam kajian ini ialah glukosa, ekstrak malt, ekstrak yis dan pH. Media yang 
optimum mengandungi 8.39 gL-1, 18.34 gL-1, 14.71 gL-1 daripada ekstrak yis, 
glukosa dan ekstrak malt masing-masing pada pH 6.66 dengan menghasilkan protein 
maksumum pada 0.858 gL-1. Pertumbuhan kinetik kulat, penggunaan glukosa dan 
pembentukan produk juga telah dilaporkan. Keputusan menunjukkan bahawa pada 
kepekatan glukosa awalan 20gL-1, model “Richard-modified logistic” (R2 =0.9839) 
untuk pertumbuhan mikrob, model “modified Gompertz” (R2 =0.9610) untuk 
pembentukan produk dan model “first order non-growth associate” (R2 =0.9736) 
untuk penggunaan glukosa adalah berpadanan dengan data eksperimen. Strategi 
pengoptimuman berurutan berdasarkan kaedah satu factor pada satu masa (OFAT) 
dan rekabentuk statistik eksperimen telah digunakan untuk mengoptimumkan 
parameter bagii meningkatan penghasilan zarah nano Ag. Berdasarkan kaedah 
OFAT, tiga faktor penting yang mempengaruhi saiz zarah nano-agentum telah 
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dikenal pasti sebagai kepekatan AgNO3, suhu pengeraman dan kelajuan pengadukan. 
Nilai optimum pembolehubah bagi proses sintesis zarah nano Ag ditentu dengan 
menggunakan kaedah sambutan permukaan (RSM) berdasarkan rekabentuk Box-
Behnken. Kesahihan model ini dibangun telah disahkan dan analisis statistik 
menunjukkan bahawa keadaan operasi yang optimum adalah pada 1mmolL-1 AgNO3, 
40oC dan 230 rpm dengan saiz zarah nano Ag yang terkecil pada 7.58 nm. 
Perbandingan kajian di dalam reactor teraduh dan reactor bertekan telah dijalankan 
untuk sintesis zarah nano Ag. Didapati bahawa lebih kecil saiz zarah nano Ag (8.52 
nm) yang dihasilkan pada tekanan operasi yang tinggi (10 bar) dan suhu (150oC). 
Pencirian zarah nano yang telah dihasilkan kemudiannye dianalisa demgam 
menggunakan spektroskopi UV-vis, DLS, FTIR, TEM, dan SEM. Keputusan 
menunjukkan bahawa jalur penyerapan zarah nano Ag terletak di puncak 420 nm. 
Aktiviti antimikrob oleh zarah nano Ag yamg dihasilkan telah ditentu dengan 
menggunakan kaedah difusi cakera, dan kaedah kepekatan bakteria dan kulat 
minimum. Keputusan mencadangkan bahawa zarah nano Ag yang dihasil dengan 
menggunakan keadaan yang optimum mempunyai aktiviti antimikrob yang lebih 
tinggi berbanding dengan zarah nano Ag yang disintesi dengan keadaan tidak 
optimum. Mekanisme bio-pengurangan zarah nano Ag telah dikaji dan dicadangkan 
bahawa enzim sulfit reductase [NADPH] telah berperanan untuk bio-pengurangan 
zarah nano Ag. Ini menunjukkan bahawa enzim dirembeskan oleh P. sanguineus 
bertanggungjawab sebagai agen penurunan yang mampu untuk mensintesis zarah 
nano Ag dengan saiz kurang daripada 10 nm.  
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PROTEIN ENRICHMENT OF PYCNOPORUS SANGUINEUS FOR  
SILVER NANOPARTICLES SYNTHESIS 
ABSTRACT 
Controlling sizes of nanomaterials are attracting a great deal of attention because of 
their unit properties for achieving specific processes especially in biological and 
medical applications. In this context, Ag which possesses good antimicrobial effects 
is of interest. A simple and effective approach for the synthesis of Ag nanoparticles 
by reduction mechanism of proteins synthesized by several species of white rot fungi 
was studied. Pycnoporus sanguineus was found to produce smallest Ag nanoparticles 
with degree of monodispersity. A Box-Behnken design was employed to optimize a 
fermentation medium for the production of protein by the selected fungi.  The four 
variables involved in the study were glucose, malt extract, yeast extract and pH.  The 
optimized medium contained 8.39 gL-1, 18.34 gL-1, 14.71 gL-1 of yeast extract, 
glucose and malt extract respectively with initial pH 6.66; and produced the 
maximum protein at 0.858 gL-1. Kinetic growth of the fungi, glucose consumption 
and product formation of the tested fungus were also reported. It is showed that at 
initial glucose concentration of 20gL-1, Richard-modified logistic model (R2 
=0.9839) for microbial growth, modified Gompertz model (R2 =0.9610) for product 
formation and first order non-growth associate (R2 =0.9736) for glucose 
consumption were fittd well with the experimental data. Sequential optimization 
strategy based on one-factor-at-a-time (OFAT) method and statistical experimental 
design were employed to optimize the process parameters for the enhancement of Ag 
nanoparticles synthesis. Based on the OFAT method, three significant factors 
influencing the size of Ag nanoparticles such as AgNO3 concentration, incubation 
temperature and agitation speed. The optimum values of these process parameter for 
xxviii 
 
the synthesis of Ag nanoparticles were determined using response surface 
methodology (RSM) based on Box-Behnken design. The validity of the model 
developed was verified and the statistical analysis showed that the optimum 
operating conditions were 1mmolL-1 of AgNO3, 40oC and 230 rpm with the smallest 
Ag nanoparticles produced at 7.58 nm. Comparatives studies were conducted for the 
synthesis of Ag nanoparticles in a stirred tank and a pressurized reactor. It was 
observed that smaller Ag nanoparticles sizes (8.52 nm) were produced at high 
operating pressure (10 bar) and high operating temperature (150oC). The synthesized 
Ag nanoparticles were characterized using UV-vis spectroscopy, DLS, FTIR, TEM, 
and SEM. Results showed that Ag nanoparticles absorption band was located at a 
peak of 420 nm. Antimicrobial activities of Ag nanoparticles synthesized have been 
determined using disc diffusion method, and minimum bactericidal and fungicidal 
concentration method. The results suggested that Ag nanoparticles synthesized using 
the described optimum conditions have higher antimicrobial activities compared to 
the Ag nanoparticles synthesized from non-optimzied condition. The bioreduction 
mechanism of Ag nanoparticles was studied and it was observed that proposed 
enzyme sulfite reductase [NADPH] was found to be responsible for the bioreduction 
of Ag nanoparticles. Thus, showing that, enzyme secreted by P. sanguineus served as 
a reducing agent which capable to synthesize Ag nanoparticles with size less than 
10nm. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Background of the study 
Nanoparticles are engineered nanomaterials that are created 
through nanotechnology, a technology which manipulates matters at an atomic or 
molecular scale to form particles of nanosizes. Recently engineered nanomaterials 
have drawn a considerable attention. Engineered nanomaterials often have sizes in 
the range of 1-100 nm. As the size of particles decreased into nanosizes, it had 
manifested on the physical and chemical properties over the bulk materials 
(Chulovskaya and Parfenyuk, 2009) such as a high surface to volume ratio, high 
reactivity, surface energy and spatial confinement (Klabunde et al., 1996). Due to the 
unique physiochemical characteristic that nanoparticles possessed, they are highly 
utilized in various industries.  
Among the noble nanoparticles, Ag nanoparticles is in much demand for its 
conductive application in electronic industries such as in semiconductors (Schmid 
and Hornyak, 1997), superconductors (Henglein, 1993), super magnets (Lee et al., 
1995), and micro-electronics (de Heer, 1993). Besides, Ag nanoparticles were also 
used efficiently in optical applications for enhancing optical spectres and 
fluorescence (Liz-Marzán, 2005), surface-enhanced Raman scattering (Cao et al., 
2003) and localized surface Plasmon resonance (Endo et al., 2010; Misra et al., 
2013). One of the fast growing Ag nanoparticles sector now is in the creation of 
biocompatibility antimicrobial products such as antibacterial water filters (Jain and 
Pradeep, 2005), biosensors (Wu et al., 2006), biocatalyst (Wang, 2006), catheters 
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and prostheses for prevention of bacterial colonization (Gosheger et al., 2004; 
Samuel and Guggenbichler, 2004), and nano-engineering in therapeutic drug 
delivery (Zhang et al., 2008).  
Engineered nanoparticles are of major interest as a result of the rapid 
development in nanotechnology. Engineered nanoparticles can be made from 
different materials such as phospholipid, chitoson, polymers, carbon, silica and 
various metals (De Jong and Borm, 2008) and are designed to form different shapes 
including solid spheres, hollows, tubes, rods, and complex strands. Among the metal 
nanoparticles, silver has been used since prehistoric times for the treatment of burns 
as reported by Chung and Herbert (2001).  
Green synthesis of nanoparticles is an emerging branch of nanotechnology in 
which it uses the environmental benign materials. Besides, it also offers numerous 
benefits of eco-friendliness and compatibility for biomedical applications. The 
revolution of nanotechnology has studied the photophysical attributes of Ag 
nanoparticles and efficient addressability via a rare combination of valuable 
properties namely, optical properties associated with surface plasmon resonance, 
well developed surfaces, catalytic activity, high electrical double layer capacitance, 
etc. (Henglein, 1993). The fundamental studies of Ag nanoparticles have brought 
them to the forefront of bionanotechnology research towards the applications of 
biomedicine (Nair and Laurencin, 2007).  
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1.2 Problem statement  
 Various physical and chemical methods have been used extensively on 
industrial scale to produce monodispersed nanoparticles. The use of toxic chemicals 
and their stability are of vital concerns.  Toxic chemicals are used on the surface of 
nanoparticles and as non-polar solvents during nanoparticles synthesis.  However the 
used of toxic chemicals is not suitable in clinical fields.  Synthesizing nanoparticles 
using a green, bottom-up approach, which is regarded as safe, eco-friendly, cost-
effective and sustainable is the way forward.   
Besides that, the increasing resistance of microbial organisms to multiple 
antibiotics and the continuing emphasis on lower healthcare costs has spurred many 
researchers to develop new, effective reagent-free antimicrobial at a lower cost.  
Such problems and needs have led to the resurgence in the use of silver-based 
antiseptics that are linked to broad-spectrum activity and far lower propensity to 
induce microbial resistance than antibiotics (Jones et al., 2004). 
According to Silver and Phung (1996), antibacterial effects of silver salts 
have been noticed since ancient times; and silver is now used to control bacterial 
growth in a variety of applications including dental-related works, catheters and burn 
wound treatment (Catauro et al., 2004). In fact, it is well known that silver ions and 
silver-based compounds, with their strong biocidal effects, were highly toxic to 
microorganisms such as E. coli (Zhao and Stevens, 1998). A report by Aymonier et 
al. (2002) has shown that hybrids of Ag nanoparticles with amphiphilic hyper 
branched macro-molecules exhibited effective antimicrobial surface coating agent. 
As the demand for Ag nanoparticles increases, it is crucial to determine a cost 
effective, large scale and eco-friendly green synthesis method to synthesize Ag 
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nanoparticles.  Even though there are many green synthesis methods for the 
production of Ag nanoparticles, there has been no publication on the synthesis of Ag 
nanoparticles by locally isolated white rot macro fungi; neither were the effects of 
antimicrobial activity involved on the inhibition against various disease-causing 
microorganisms nor the mechanisms of Ag nanoparticles synthesis by 
microorganisms.  Publications on large scale production of Ag nanoparticles, 
cultivation mode for optimum production of Ag nanoparticles in bioreactors are 
limited. This research will provide an alternative to the industry to produce Ag 
nanoparticles biologically.  On the other hand, there are many proposed mechanisms 
of Ag nanoparticles synthesis by fungi strains (Ottow and Von Klopotek, 1969; 
Durán et al., 2005), but the exact mechanism of action on how Ag nanoparticles is 
produced through microbial synthesis is still not known. The use of proteomics work 
such as SDS-PAGE, HPLC, and LC-MS/MS further confirmed the synthesis 
reaction of Ag nanoparticles by the selected fungi.   
 
1.3 Research objectives 
The measureable objectives are as follow: 
(a) To screen the capability of the selected fungus for Ag nanoparticles synthesis 
in shake flask cultures 
(b) To optimize the process variables for growth and protein excretion by 
selected fungus through statistical optimization and kinetics studies of the 
selected fungus in an airlift bioreactor. 
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(c) To optimize the synthesis of Ag nanoparticles in shake flasks using statistical 
tools and comparative studies of Ag nanoparticles synthesis in a stirred tank 
and pressurized reactor. 
(d) To study the synthesis mechanism, characterization and antimicrobial 
activities of the synthesized Ag nanoparticles.  
 
1.4 Scope of study 
Different species of white rot fungi were screened by cultivating them in malt 
extract nutrient broth at 30oC, 200 rpm for 3 days, and then challenged with silver 
nitrate solution (1mM, 30oC, 200 rpm, and 5 days) for the bioreduction process. In 
Ag nanoparticles synthesis, different synthesis routes were studied such as:  
(a) bioreduction of silver ion in the cell free culture supernatant 
(b) bioreduction of silver ion by absorption of silver atom on the mycelia pellet 
(c) bioreduction of silver ion from the mycelia pellet which was released into the 
silver nitrate solution 
The species that showed the highest production of Ag nanoparticles was 
selected for further analysis. In order to identify the bio-reducing molecules that 
were present in the reactions, the cell culture was subjected to protein separation and 
purification using size-exclusion chromatography column, and sodium-dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Next, the positive 
fraction was then analyzed by an orbitrap nano LC-MS/MS system.  
 Various analytical tools were used to characterize the synthesized Ag 
nanoparticles either in the form of intracellular or extracellular, such as UV-vis 
spectrophotometer, dynamic light scattering, atomic absorption spectrophotometer, 
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scanning electron microscopy, energy dispersive X-ray spectroscopy, and 
transmission electron microscopy.  
 For optimization studies, a one-factor-at-one-time (OFAT) method and a 
design of experiment (DoE) were employed.  OFAT was used as a preliminary step 
to determine the influencing factors before subjecting each factor to a statistical 
analysis. In fungal cultivation, glucose, yeast extract, malt extract and pH were 
selected as the influencing factors for growth and protein excretion. For Ag 
nanoparticles synthesis, the variables studied were stabilizer concentration, AgNO3 
concentration, inoculum percentage, temperature and agitation. For statistical 
analysis, a Design Expert software version 6.1.10, (State-Ease, Inc, USA) was used 
for the analysis of DoE. In this method, all variables obtained from OFAT were 
varied simultaneously according to the set of experimental runs generated by the 
software using response surface methodology (RSM) coupled with Box-Behnken 
design (BBD).   
To describe the kinetics of Ag nanoparticles producing fungus in an air-lift 
bioreactor, different kinetics models for microbial growth, product formation, 
glucose consumption and inhibition study were selected. These models were then 
validated using the correlation of coefficient (R2) and mean square error (MSE). 
Models with the best fitted experimental data were then chosen as the working 
models.   
 Several process studies were performed on the synthesis of Ag nanoparticles. 
Ag nanoparticles were first synthesized in shake flasks and then the optimized 
conditions obtained were then used in reactors (pressurized reactor and stirred tank 
reactor) synthesis. The Ag nanoparticles synthesis was performed in a 8L reactor 
with controlled temperature and agitation speed. Later, the process was then 
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compared with synthesized Ag nanoparticles in a pressurized reactor of varied 
temperatures (38oC & 150oC) and pressures (1 bar & 10 bar). The process which 
synthesized Ag nanoparticles in the most effective way was suggested as the best 
scale-up process in Ag nanoparticles synthesis.  
  
1.5 Organization of the thesis 
 The first chapter introduces the Ag nanoparticles, the available synthesis 
method followed by determination of research objectives and scope of study for this 
research project. 
   Chapter two gives further insight on the capability of white-rot fungi in Ag 
nanoparticles synthesis, reviews on the methods for synthesis of Ag nanoparticles. 
The multi-disciplinary studies on bionanotechnology and the applications of Ag 
nanoparticles are also discussed. Characterization techniques used for the analysis 
are elaborated. Reviews of kinetics and modeling of process studies will also be 
presented. 
 In materials and methods (Chapter three), list of all materials and chemical 
used in the research are listed. Detailed procedures for the fungus cultivation and Ag 
nanoparticles synthesis are presented. This chapter also illustrates comprehensively 
the analytical methods used in both identification of bio-reducing molecules and 
characterization of the synthesized Ag nanoparticles. 
 Chapter four discusses all the experimental data obtained. Firstly, the 
selection of white-rot fungi species and production routes of Ag nanoparticles are 
presented. It is then followed by the characterization studies of synthesis of the Ag 
nanoparticles. Discussion on the bioreduction mechanism of Ag nanoparticles by 
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biomolecules and mechanistic action of Ag nanoparticles on microbial system are 
also presented. Statistical methods used to determine the effect of interaction 
between process variables towards the responses and optimization of the responses 
will be discussed. The most effective way in large-scale production of Ag 
nanoparticles will also be reported.  
 Chapter five concludes concisely all the major findings in this present 
research work. Suggestions and future recommendations are also presented for future 
studies.  
  
 
  
9 
 
CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Introduction 
This section reviews the potential of Ag nanoparticles in bionanotechnology and the 
use of Ag nanoparticles in various industries. The literatures regarding the 
biosynthesis of Ag nanoparticles by fungi are also presented. This chapter also 
reviews the various approaches reported for the elucidation of the kinetics of fungi 
cultivation and Ag nanoparticles formation.  
 
2.2 Bionanotechnology 
 Nanotechnology involves science and technology that manipulate precisely 
matters at nano-scale. It forms the bridge between different disciplines including 
engineering, chemistry, electronics, etc. with the concern of bringing the existing 
technologies to nano-scale (Battard, 2012). The term nanotechnology draws its name 
from the prefix “nano”. It comes from the Greek word “nanos” meaning “a dwarf”. 
Hence nanotechnology refers to the technology in applying materials or devices with 
characteristic length scales less than 100 nm. In 2011, the Office of Basic Energy 
Sciences (BES) for the U.S. Department of Engineering gave illustration between the 
micro- and nanoworld by comparing the natural and manmade materials in the title 
“The Scale of Things” as shown in Plate 2.1.  
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Plate 2.1 Micro- and nanoworld  
(Source: Office of Basic Energy Science, US Deparment of Energy, 
http://science.energy.gov/bes/news-and-resources/scale-of-things-chart/) 
 
The basic concept of nanotechnology was first described by Nobel Prize 
winning physicist, Richard Feynman in 1959 in his talk “There’s Plenty of Room at 
the Bottom” (Feynman, 1992). Later, Taniguchi coined the term “nano-technology” 
to describe ion-sputter machining (Taniguchi, 1974). Then, nanotechnology had 
evolved from a concept to rigid technology by the birth of cluster science and the 
invention of the scanning tunnelling microscope (STM). Nanotechnology is now 
advancing with production of evolutionary nanotechnology products and processes 
such as carbon nanotubes, nanocomposites, nanoparticles, nanopatterning, quantum 
dots for medical imaging, etc. (Fu et al., 2005; Khosravi-Darani et al., 2007; 
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Sakamoto et al., 2010; Jaganathan and Godin, 2012). Today, with the revolution of 
nanotechnology, the cross marriage between molecular biology and nanotechnology 
has been introduced.  
In the biomedical context, bionanotechnology are consider a pragmatic 
approach as nanotechnology through biotechnology (Sarikaya et al., 2003) such as 
engineered nanostructures and nanomachines or naturally occurring cell machinery 
with submicron biological molecules such as proteins, peptides, DNA, RNA in a 
living organism (Zahid et al., 2013). The self-assembling nature of biological 
macromolecules such as protein, peptide, etc is important for the engineered 
nanostructure of molecular templates and supra-molecular structures (Zhang, 2003). 
The self-assembly biomolecules are crucial in recognizing complementary regions 
where it is a base for the binding and building of tissues and organs from these 
biomolecules. Most of the biomolecules such as proteins are amphiphile in nature; 
resulting the high biocompatibility for attachment to various materials because they 
could maintain their structure and conformation in both hydrophilic and hydrophobic 
environments (Kiselev, 2006).  The wide physiological diversity, small size, genetic 
manipulability and controlled culturability, microbial cells are an ultimate 
nanofactory for the production of engineered nanostructure, materials and 
instruments in bionanotechnology (Villaverde, 2010).  
It is frequently observed that most features or characteristics of nanoparticles 
are size-dependent. Therefore, the properties of nanoparticles are enhanced and 
modified as its nanosize is scaled down further. Although nanoparticles seem to have 
desirable advantages, the disadvantages are seen with the revolution of 
bionanotechnology. Cancer therapy becomes possible with bionanotechnology 
however; the cost of treatment becomes expensive and is hardly affordable to 
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patients. Direct injection of nanoparticles into the blood stream is worrying as there 
is still unknown side-effects to the patients (Lara et al., 2009). A dilemma occurs 
with developing technology-intensive treatment, they are inaccessible to patients 
who need them most. In a nutshell, bionanotechnology is a life enhancing 
advancement. Intensive investigations are required to put bionanotechnology into the 
hands of the end-user, such as looking into cost-effective production and 
commercialization, and making bionanotechnology safer by subjecting nanodrug 
candidates to clinical trials.  
The director of the Centre for System Biology at Massachusetts General 
Hospital (MGH), Dr. Weissleder has developed systematic way to explore disease 
biology using bionanotechnology (Bogdanov Jr et al., 1999; Jaffer et al., 2006a; 
Jaffer et al., 2006b). Also, Nadarajah (2009) refers bionanotechnology as “pedestrian 
applications” of a very powerful science.  Some really interesting work is happening 
in the medical industry. For example, Ag nanoparticles have shown to have better 
antimicrobial activity against bacteria, yeast and fungus where currently there are 
publications confirming that Ag nanoparticles (Elechiguerra et al., 2005; Lara et al., 
2010) and nano-emulsion (Rueter, 2008) vaccines can exert antiviral activity against 
HIV-1. Thus, it is believed that bionanotechnology is a new area especially in 
medical application for antimicrobial and antiviral diseases.   
Researchers from Stanford Center for Magnetic Nanotechnology conducted 
researches on the incorporation of computer chips inside living cells (Xu et al., 
2008b; Gaster et al., 2011) which is the future area of bionanotechnology. As 
biological processes occur inside cells and are greatly important in biomedicine and 
in biological traceability, development of nano-chips in living cells could help in 
understanding the biochemical and transport processes at celleular level. A more 
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challenging area of bionanotechnology in medical application would be cancer 
therapy. After decades of clinical trials, recently there were evidences that therapies 
based on bionanotechnology have been effective in humans (Garcia-Bennett et al., 
2011; Gou et al., 2011; Lee and Wong, 2011). Researchers also demonstrated that 
increasing the amount of nanoparticles injected into human bloodstreams increased 
the efficiency of the treatment. However, the researches on cancer and 
bionanotechnology are related more to diagnosis and therapy. In the near future, 
nanodiagnostic devices could revolutionize the biomedical industry.  
 
2.2.1 Ag nanoparticles in bionanotechnology  
There are basically three types of nanoparticles: metallic, semiconductor and 
polymeric nanoparticles (Liu, 2006). They display fascinating properties which 
differ from those of individual atoms, surfaces or bulk materials. Metallic 
nanoparticles include gold nanoparticles and nanoparticles which are produced from 
magnetized metals such as iron, nickel, cobalt etc.  As magnetized nanoparticles are 
produced from magnetized bulk metals, they have the ability to manipulate external 
magnetic field gradient which is very useful in identifying biomolecules.  Quantum 
dot refers to semiconductors in nanosize whose excitons are confined in all three 
spatial dimensions (Fu et al., 2005). The unique properties of fluorescence have been 
studied.  Even though the size-dependent photostability properties have been 
discovered by Efros et al. (1996), water insolubility properties of quantum dot is a 
challenge towards biocompatibility issue associated with biological molecules.   
Recently, many studies have been conducted to overcome this issue which will be 
discussed further. Biological molecules which are nanosize such as dendrimers and 
liposomes are classified as polymeric nanoparticles.  Dendrimers are complex 
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molecule with very well-defined chemical structures which are nearly perfect 
monodisperse and highly branched in three dimensional structures.  Biologically 
inert properties of dendrimers create the interest in pharmaceutical and biomedical 
applications which act as a multifunctional nanodevice.  
Ag nanoparticles are of concern due to its optical and antimicrobial 
properties. The optical properties of Ag has been studied for diagnosis and imaging 
in biomedical application. The remarkable optical properties of Ag nanoparticles are 
related to the localized plasmon resonance which lies in the visible spectral range 
(Haes and Van Duyne, 2002). It was reported that the frequency of surface plasmon 
resonance depends on several factors such as shape, size, dielectric constant of metal 
nanoparticles, interparticles interaction and electron density (Jain et al., 2006) . The 
characteristic feature of absorption band and scattering spectra of Ag nanoparticles 
of different shapes and sizes are illustrated in Figure 2.1. It was observed that the 
absorption band of metal nanoparticles is located in the visible range or in the 
adjacent near-IR and UV region. This band is known as surface plasmon resonance 
(SPR) or the Mie resonance. Ag nanoparticles have shown to exhibit highest 
extinction ratio in the SPR band peak among all metals and materials that are known 
to absorb in the same spectral range (Yu et al., 2008). The SPR band occurred as a 
result of the interaction of light on the nanoparticles surface with the conduction 
electrons of the metals (Xia and Campbell, 2007).  
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Figure 2.1 Absorption and scattering spectra of metal nanoparticles based on (a) 
shape (Liz-Marzán, 2007), (b) sizes (Lee et al., 2008) 
 
In the electron-gas theory, the core electrons are localised at the atomic 
nucleus while the outer electron are mobile within the metal particles. By alternating 
the electric field, the mobile conduction electrons are shifted as illustrated in Figure 
2.2. The total cross-section of light absorption and scattering by a particle (Cext) was 
described in Mie theory (Jain et al., 2007) and shown in Equation (2.1).  
Mie theory: : 𝐶𝑒𝑒𝑒 = 24𝜋2𝑅𝑅3/2𝑀𝜆 𝑅2(𝑅1+2𝑅𝑀)2+𝑅22        (2.1) 
where, ε = ε1(λ) + iε2(λ) is the wavelength dependent, complex dielectric function of 
the nanoparticles materials, 𝜀𝑀 is the dielectric permittivity of the medium, 𝜆 is the 
incident light wavelength,  R is the particles radius. 
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 According to Equation (2.1), Cext is proportional to particle radius hence 
indicating SPR band intensity increases with the increase in the particle radius. It has 
been shown that the growth of Ag nanoparticles is accompanied by the increase of 
SPR absorption band intensity and broadening of SPR band (Mertens et al., 2004).  
Factors that contribute to the electric oscillations were due to acceleration of the 
conduction electrons by the electric field, presence of restoring forces, and 
confinement of the electrons to dimensions smaller than the wavelength of light 
(Ravindran et al., 2013).  
 
 
 
Figure 2.2 Interaction of electromagnetic radiation with metal nanoparticles 
(Willets and Van Duyne, 2007) 
 
 It was reported by Nie and Emory (1997), the size-dependent localized 
surface plasmon resonance contributes to surface enhanced Raman signals for the 
detection of single molecules. Hence, the detection of various biomolecules using 
SERS plasmonic sensors has received significant attention. Shanmukh et al. (2008) 
reported Ag nanoroad were used to determine the Raman spectra of Respiratory 
Syncytical Virus. The extraordinary power of SERS exhibited by Ag nanoparticles 
as biosensors is being increasingly exploited in nanodiagnostic and nano-imaging 
industries.  
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2.2.2 Antimicrobial properties of silver nanoparticles 
Besides optical properties, Ag possesses powerful antimicrobial properties in 
its bulk material and is historically recognized as a powerful biocide against bacteria, 
viruses and fungi. Decreasing particle dimensions into nanosizes have manifested on 
the physical properties over bulk materials (Chulovskaya and Parfenyuk, 2009). Ag 
nanoparticles were reported to be highly dispersed and posed higher surface area 
which indirectly intensified antimicrobial properties and served as an effective 
antimicrobial agent (Illic et al., 2009). Pal et al. (2007) also discovered that besides 
size, shape of the nanoparticles is also important for antimicrobial activity, with 
triangular nanoparticles showing higher antibacterial activity compared to other 
shapes. In addition, Cho et al. (2005) reported functionalizing material on Ag 
nanoparticles was important and could influence the activity with the target 
microorganism.  
Issues in antibiotic resistance in pathogenic and opportunistic 
microorganisms are dramatically increasing. Although new antibiotics have been 
constantly developed and introduced to the pharmaceutical industry, none of them 
were susceptible to the multidrug-resistant bacteria (Conlon et al., 2004). According 
to Silver and Phung (1996), the antibacterial effects of Ag salts have been noticed 
since antiquity where Ag nanoparticles have demonstrated strong antimicrobial 
activities in recent year. Therefore, Ag nanoparticles are considered an attractive 
alternative to antibiotics.  It was also reported that Ag ions and Ag based compounds 
were highly toxic to microorganisms, thus showing strong biocidal effects to as 
many as 12 species of bacteria including Escherichia coli (Zhao and Stevens, 1998). 
Aymonier et al. (2002) then showed that hybrids of Ag nanoparticles with 
amphiplilic hyperbranched macromolecules exhibited effective antimicrobial surface 
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coating agents. Recently, researchers have shown Ag nanoparticles exhibited 
antivirial and cytotoxic properties against human immunodeficiency virus (HIV), 
hepatitis B virus (HBV) and H1N1 influenza A virus (Elechiguerra et al., 2005; 
Xiang et al., 2011; Trefry and Wooley, 2012).  
The antimicrobial effects of silver and their derivatives are well documented, 
however the mechanisms by which it exerted its bioactivity are still unclear. Several 
proposals have been developed to explain the mechanisms for the bactericidal effects 
of silver ion/silver metal on bacteria.  It was reported that heavy metals reacted with 
proteins by combining cysteine (CySH) and thiol (-SH) groups such as sodium 
thioglycollate, which then lead to the inactivation of the proteins (Liau et al., 1997; 
Lehninger et al., 2011). Also, it was reported that silver in an oxygen-charged 
aqueous media catalysed the complete destructive oxidation of microorganisms 
(Davies and Etris, 1997). While various hypotheses have been proposed to explain 
the mechanism of antimicrobial activity of Ag nanoparticles, it was widely believed 
that Ag nanoparticles was incorporated in the cell membrane, which caused leakage 
of intracellular substances and eventually caused cell death (Sondi and Salopek-
Sondi, 2004; Cho et al., 2005).  
Nevertheless, it was reported that the bactericidal effect of Ag nanoparticles 
decreased as their size increased, and the shape of their particles is also an important 
influencing factor for their bactericidal power (Panacek et al., 2006; Pal et al., 2007). 
Although most studies have utilized spherical particles, Pal et al. (2007) showed that 
truncated triangular shape particles have greater bactericidal effect compared to that 
of spherical and rod-shaped particles. Concisely, the antimicrobial activity of silver 
nanoparticles was reported to have comparatively better than the prominent broad-
spectrum antibiotics used in the pharmaceutical market (Roy et al., 2007).  
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 The antimicrobial activity of Ag nanoparticles were often determined by 
using minimum inhibitory concentration (MIC), minimum bactericidal concentration 
(MBC), half effective concentration (EC50), median lethal dose (LD50), well-
diffusion and disc diffusion methods. Table 2.1 showed the antimicrobial activity of 
Ag nanoparticles with different sizes and concentrations acting on various 
pathogens. Although Ag nanoparticles showed strong antimicrobial action towards 
microorganisms, the exact mechanism of action of Ag nanoparticles on the microbes 
for its excellent antimicrobial properties is still not known, but the possible 
mechanisms of action have been suggested according to the morphological and 
structural changed found in the bacterial cells as illustrated in Plate 2.2.  
 Feng et al. (2000) suggested that silver ions enter into the bacterial cells by 
penetrating through the cell wall and consequently alter the DNA into a condensed 
from which reacted with the thiol group proteins and result in cell death. Cho et al. 
(2005) in the research suggested two possibilities of antimicrobial action. The 
negatively charged surface of the sodium dodecylsulfate interferes with the 
absorption surface of microbial which has negative charges on the surface of Ag 
nanoparticles. The other reason suggested for the absorption of Ag was due to the 
dissolved Ag ions in Ag nanoparticles solution that probably interacted directly with 
the negatively charged SDS. This electrostatic effect prevents the interaction 
between Ag ion and microbial system. Ruparelia et al. (2008) demonstrated the 
antimicrobial activity due to the release of ions.  The presence of nanoparticles in 
suspension would ensure continuous release of ions into the nutrient media.  Silver 
ions released by the nanoparticles may attach to the negatively charged bacterial cell 
wall and cause a rupture, and thereby leading to protein denaturation and cell death. 
Siva Kumar et al. (2004) proposed that oxygen associates with silver and reacts with 
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the sulfhydryl (-S-H) groups on cell wall to form R-S-S-R bonds thus blocking 
respiration and cause death of cells. Meanwhile Lok et al. (2006) reported that the 
attachment of both silver ions and Ag nanoparticles to the cell wall may cause 
accumulation of enveloped protein precursors which resulted in dissipation of the 
proton motive force. Ag nanoparticles also exhibited destabilization of the outer 
membrane and rupture of the plasma membrane, thereby causing depletion of 
intracellular ATP.    
 
Plate 2.2  Proposed mechanistic action of Ag nanoparticles on microorganism 
(Huh and Kwon, 2011) 
 
Ag nanoparticles have been shown to be a promising antimicrobial agent and 
considered as an option for antiviral treatments. It was reported that Ag nanoparticles 
can inhibit viral replication of viruses such as HIV-1 (Elechiguerra et al., 2005; Lara 
et al., 2010), hepatitis B virus (Lu et al., 2008), respiratory syncytial virus 
(Shanmukh et al., 2008; Sun et al., 2008), herpes simplex virus type 1 (Baram-Pinto 
et al., 2009), monkeypox virus (Rogers et al., 2008), H1N1 influenza A virus (Xiang 
et al., 2011), avian influenza virus, H5N1 (Jazayeri et al., 2012), etc. Hence, it is  
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Table 2.1 Overview of the antimicrobial activity of Ag nanoparticles produced in different sizes 
References Sizes & Concentration Pathogen Antimicrobial method Inhibition 
Martinez-Gutierrez et al. 
(2010) 
20 - 25 nm 
107.8 µg/mL 
B. subtilis, M. bovis, M. smegmatis, MRSA, 
S. aureus, A. baumanii, E. coli 
MIC 
 
0.4 - 1.7 µg/mL 
 
A. niger, C. albicans, C. neoformans 3 - 25 µg/mL 
THP-1 cells 
 
LD50 10 + 3.4 µg/mL 
Nanda and Saravanan 
(2009) 
 
2 µg / 20 µL MRSA, MRSE, S. pyogens, S. typhi Well diffusion 11 - 18 mm  
Ruparelia et al. (2008) 2.26 - 10.34 nm E. coli, B. subtilis, S. aureus MIC 40 - 180 µg/mL 
MBC 60 - 220 µg/mL 
 
Wani et al. (2013) 8 - 40 nm E. coli MIC 50 - 100 µg/mL 
Disc diffusion 8 - 16 mm 
C. albicans MIC 30 - 60 µg/mL 
Disc diffusion 13 - 24 mm 
 
Bankura et al. (2012) 0.2 mg/mL B. subtilis, B. cereus, E. coli, S. 
aureus and P. aeruginosa 
Disc diffusion 
 
 
21 - 36 mm 
Logeswari et al. (2013) 22.3 - 65 nm S. aureus, P. aeruginosa, E. coli and K. 
pneumoniae 
 
Well diffusion 12 - 30 mm 
Sathishkumar et al. (2009) 2 - 50 mg/L  Escherichia coli BL-21 EC50 11+ 1.72 mg/L 
 
Sintubin et al. (2011) 11.2 + 0.9 nm S. aureus,  E. coli, P. aeruginosa MBC 50 - 200 mg/L 
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interesting to study the interaction between Ag nanoparticles and the particular 
viruses that caused their inactivation. Elechiguerra et al. (2005) conducted a high 
angle annular dark field (HAADF) scanning transmission electron microscopy to 
study the interaction of Ag nanoparticles with HIV-1 as illustrated in Plate 2.2 It was 
clearly shown that Ag nanoparticles were bound to the viral shell and caused the 
inactivation. The viral shell generally comprised of a lipid membrane intermingled 
with glycoprotein knobs consisting of gp120 surface glycoprotein and gp41 
transmembrane glycoprotein connected with protein p 17 (Forster et al., 2000). It 
was believed that Ag nanoparticles attacked the gp120 surface glycoprotein which 
plays the key role in recognition and binding of the viral particle to the host cell 
through the receptor region CD-4.  
 
2.3 Market analysis on Ag nanoparticles 
The antibacterial, antifungal and antiviral properties of Ag nanoparticles have been 
well known. Hence it is necessary to study the market demand of Ag nanoparticles 
locally and globally to ensure a constant supply to fit consumer needs.  
 
2.3.1 Global market on nanoparticles research 
With the emerging markets of nanotechnology, the 2013 National Federal 
Budget of United States have provided US$1.8 billion for the National 
Nanotechnology Initiative (NNI) in the development of nanotechnology (Nano.org, 
2000). According to Bombourg (2012) in the research report titled “Nanotechnology 
Market Forecast to 2014”, the United States nanotechnology market is rapidly 
growing with CAGR of about 19% during the year 2011-2014. The most prominent 
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field in nanotechnology involved mostly the biomedical, biopharmaceutical and 
electronics industries. Highsmith (2012) stated that the total market values for 
nanoparticles in biotechnology, drug development and drug delivery have been 
increased from US$ 16 billion in 2011 to US$ 24 billion in 2012 and expected to 
increase at least 3-fold in year 2017 as illustrated in Figure 2.3.  
 
 
Figure 2.3 Total market values for nanoparticles in biotechnology, drug 
development and drug delivery (Source: National Nanotechnology Initiative, 
http://www.nano.gov/) 
 
 Of all the nanoparticles, Ag nanoparticles have been reported as the highly 
developed nanoparticles. As shown in Figure 2.4, Ag nanoparticles associated 
products have increased about 12-fold in year 2011 from year 2006 according to 
Rejeski et al. (2011).  
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Figure 2.4 Numbers of products associated with specific nanoparticles (Source: The 
Project on Emerging Nanotechnologies, www.nanotechproject.org)  
 
2.3.2 Nanotechnology industries in Malaysia 
 The development of nanotechnology has influenced the Asia-Pacific region 
and was reported that this region has experienced the fastest growth with CAGR 
pegged at around 52% in the forecast period (NanowerkNews, 2009). In Malaysia, 
the development of nanotechnology has started since early 2001 under the 
Intensification of Priority Research Area (IRPA) in Eight Malaysian Plan (8MP) 
which spanned between 2001 to 2005 and was funded by MOSTI (Hashim et al., 
2009). They reported that the main research focused on three categories such as 
material and manufacturing, nanoelectronic and computer technology, and life 
sciences/ medicine and health. Although in Malaysia, nanotechnology is still at its 
infancy, the initiative in forming National Nanotechnology Directorate (NND) has 
showed the pivotal role in coordinating and synergizing the development of 
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